Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The investigators hypothesize that everting wound edges while suturing surgical sites will result in more aesthetic scars. Additionally, we also hypothesize that small to moderate wound irregularities present at 3 months will resolve by 6 months after surgery with no intervention
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Everted suture technique | Active Comparator | Technique that everts the skin; the edges will sit up against each other in a little peak, raised above the surrounding skin. |
|
| Non-everted suture technique | Active Comparator | Surgical wound will be approximated such that the suture line is flat relative to the surrounding skin. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Everted suture technique | Procedure |
| ||
| Non-everted suture technique |
| Measure | Description | Time Frame |
|---|---|---|
| Everted versus non-everted suturing techniques | Primary outcome measures for this study are the post operative scar width measured at 1 cm from the midline on both sides of the scar. | 3 and 6 months |
| Mean score of sum of 2 blinded observers POSAS scores | The mean summed total of two blinded reviewers Physician Observer Scar Assessment Scale (POSAS) scores for each side of the wound. | 3 and 6 months |
| Scar measurements (height, width, length) | Scar volume will be measured in centimeters on both sides of the wound | 3 and 6 months |
| Scar induration | Scar induration area will be measured in centimeters for both sides of the wound | 3 and 6 months |
| Scar erythema | Scar erythema area will be measured in centimeters for both sides of the wound | 3 and 6 months |
| Wound contour irregularities | Wound contour irregularities will be measured in terms of volume in cubic centimeters via a length, width and height measurement | 3 and 6 months |
| Stand cone volume | The volume of standing cones will be measured via length, width and height measurements in centimeters | 3 and 6 months |
| Measure | Description | Time Frame |
|---|---|---|
| Infection | Infections occurring anytime during the study period will be recorded | up to 6 months |
| wound dehiscence | incidence of wound infection will be recorded anytime during the study period |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Daniel Eisen, M.D. | University of California, Davis | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| UC Davis, Department of Dermatology | Sacramento | California | 95816 | United States |
Not provided
| Label | URL |
|---|---|
| University of California-Davis Department of Dermatology Clinical Research | View source |
Not provided
Not provided
| ID | Term |
|---|---|
| D002280 | Carcinoma, Basal Cell |
| D002294 | Carcinoma, Squamous Cell |
| D008545 | Melanoma |
| ID | Term |
|---|---|
| D002277 | Carcinoma |
| D009375 | Neoplasms, Glandular and Epithelial |
| D009370 | Neoplasms by Histologic Type |
| D009369 | Neoplasms |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Procedure |
|
| Uneven edge measurement |
The area of uneven edges will be measured via a length x height measurement in centimeters |
| 3 and 6 months |
| Hyperpigmentation area | areas of hyperpigmentation will be measured via a length x width measurement in centimeters | 3 and 6 months |
| up to 6 months |
| spitting sutures | spitting sutures will be counted for each side of the wound at 3 and 6 months | 3 and 6 months |
| D018295 |
| Neoplasms, Basal Cell |
| D018307 | Neoplasms, Squamous Cell |
| D018358 | Neuroendocrine Tumors |
| D017599 | Neuroectodermal Tumors |
| D009373 | Neoplasms, Germ Cell and Embryonal |
| D009380 | Neoplasms, Nerve Tissue |
| D018326 | Nevi and Melanomas |
| D012878 | Skin Neoplasms |
| D009371 | Neoplasms by Site |
| D012871 | Skin Diseases |
| D017437 | Skin and Connective Tissue Diseases |